NR 293 Exam 3 Pharmacology for Nursing Practice |
2026/2027 Edition | 200 Verified Questions - 190 Questions
with Answers
NR 293 Exam 3 Pharmacology for Nursing Practice 2026-190 QUESTIONS AND ANSWERS ALREADY GRADED
A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document is meticulously designed for nursing students enrolled
in NR 293 Pharmacology for Nursing Practice. It contains 200 verified questions that reflect the actual
exam content, providing detailed rationales for each answer to enhance understanding and retention.
The material is organized to cover all major pharmacological principles, drug classifications, and
nursing interventions, ensuring a thorough review. With a focus on clinical application and safety, this
resource is an indispensable tool for achieving a top grade in the course.
Key Features:
Pharmacokinetics and Pharmacodynamics: Absorption, Distribution, Metabolism, Excretion, and
Drug-Receptor Interactions
Drug Classification and Prototype Drugs: Major Classes Including Antibiotics, Analgesics, Cardiovascular, and
CNS Agents
Nursing Process in Pharmacology: Assessment, Diagnosis, Planning, Implementation, and Evaluation
Patient Education and Health Promotion: Medication Teaching, Adherence, and Lifestyle Modifications
Safety and Error Prevention: High-Alert Medications, Look-Alike/Sound-Alike Drugs, and Adverse Reaction
Monitoring
Legal and Ethical Considerations: Controlled Substances, Prescriptive Authority, and Patient Rights
Cultural and Lifespan Considerations: Pediatric, Geriatric, Pregnancy, and Cultural Variations in Drug
Response
Herbal and Over-the-Counter Medications: Interactions and Nursing Implications
Antimicrobial Therapy: Antibiotics, Antivirals, Antifungals, and Resistance Mechanisms
Cardiovascular Pharmacology: Antihypertensives, Antiarrhythmics, Antianginals, and Lipid-Lowering Agents
Respiratory Pharmacology: Bronchodilators, Corticosteroids, and Antihistamines
Neurological and Psychiatric Pharmacology: Anticonvulsants, Antidepressants, Antipsychotics, and
Anxiolytics
Endocrine Pharmacology: Insulin, Oral Hypoglycemics, Thyroid Hormones, and Corticosteroids
Gastrointestinal Pharmacology: Antacids, Antiemetics, Laxatives, and Antidiarrheals
Renal and Fluid/Electrolyte Pharmacology: Diuretics, Electrolyte Supplements, and Acid-Base Regulators
Oncology and Immunomodulators: Chemotherapeutic Agents, Biologic Response Modifiers, and
Immunosuppressants
Emergency and Critical Care Pharmacology: Vasopressors, Antidotes, and Reversal Agents
Pain Management and Anesthesia: Opioids, NSAIDs, Local and General Anesthetics
Updates for 2026:
- Updated to reflect the latest 2026/2027 NR 293 exam blueprint and course objectives
- Incorporated recent FDA drug approvals and safety alerts relevant to nursing practice
- Enhanced rationales with evidence-based guidelines from the American Nurses Association and specialty
organizations
- Revised to include new NCLEX-style questions that emphasize clinical judgment and prioritization
- Expanded coverage of high-alert medications and medication error prevention strategies
Page 1
,Abstract:
This exam preparation document for NR 293 Pharmacology for Nursing Practice is a meticulously curated
collection of 200 verified questions and answers, designed to mirror the actual 2026/2027 Chamberlain University
exam. Each question is accompanied by a detailed rationale that explains the correct answer and distracts the
incorrect options, facilitating a deep understanding of pharmacological principles and their clinical applications.
The content spans the entire course syllabus, from foundational concepts of pharmacokinetics and
pharmacodynamics to complex drug therapies across various body systems. Emphasis is placed on the nursing
process, patient safety, and evidence-based practice, ensuring that students are well-prepared not only for the
exam but also for real-world nursing scenarios. The document is structured to promote active recall and critical
thinking, with questions that range from basic recall to application and analysis. By engaging with this material,
students will reinforce their knowledge, identify areas for improvement, and build confidence to excel in the exam
and in their future nursing careers.
Keywords:
NR 293 Exam 3, Pharmacology for Nursing Practice, Chamberlain University, Verified Questions, Detailed
Rationales, NCLEX-style, Nursing Pharmacology, 2026-2027
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is indicated, followed
by a comprehensive rationale explaining why it is correct and why the other options are incorrect. Rationales
include pharmacological mechanisms, nursing considerations, and clinical pearls to reinforce learning and
application.
Compliance Checklist:
Aligned with Chamberlain University NR 293 course objectives and exam blueprint
Updated to reflect 2026/2027 academic year and current clinical guidelines
Includes 100% verified questions and answers with detailed rationales
Covers all major drug classifications and nursing implications
Designed to promote critical thinking and clinical judgment
Suitable for NCLEX-RN preparation and pharmacology mastery
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacokinetics and 1-20 Absorption, Distribution, Metabolism, 10%
Pharmacodynamics Excretion, Drug-Receptor Interactions,
Half-Life
Drug Classification and 21-40 Major Drug Classes, Prototype Drugs, 10%
Prototype Drugs Therapeutic Equivalence
Nursing Process and Patient 41-60 Assessment, Planning, Implementation, 10%
Education Evaluation, Teaching Strategies
Safety and Error Prevention 61-80 High-Alert Medications, 10%
Look-Alike/Sound-Alike, Adverse
Reactions, Medication Reconciliation
Antimicrobial Therapy 81-100 Antibiotics, Antivirals, Antifungals, 10%
Resistance, Culture and Sensitivity
Cardiovascular Pharmacology 101-120 Antihypertensives, Antiarrhythmics, 10%
Antianginals, Lipid-Lowering Agents
Respiratory and Neurological 121-140 Bronchodilators, Corticosteroids, 10%
Pharmacology Anticonvulsants, Antidepressants,
Antipsychotics
Page 2
,Endocrine and Gastrointestinal 141-160 Insulin, Oral Hypoglycemics, Thyroid 10%
Pharmacology Hormones, Antacids, Antiemetics
Renal and Fluid/Electrolyte 161-180 Diuretics, Electrolyte Supplements, 10%
Pharmacology Acid-Base Regulators
Oncology, Emergency, and Pain 181-200 Chemotherapy, Immunomodulators, 10%
Management Vasopressors, Antidotes, Opioids, NSAIDs
Page 3
, Q1. A client receiving a drug that is a weak acid has a urine pH of 8.5. How does this
affect drug excretion?
A. Increased reabsorption, reduced excretion
B. Increased excretion due to ion trapping
C. No change in excretion
D. Decreased excretion due to protein binding
Correct Answer: B. Increased excretion due to ion trapping
Rationale: Weak acids ionize in alkaline urine, becoming less lipid-soluble and unable to
cross tubular membranes, thus increasing excretion. Option A describes the effect in acidi
c
urine. Option C is incorrect because pH alters ionization. Option D is unrelated to pH
effects.
Why Wrong:
A - This is the opposite: weak acids are reabsorbed in acidic urine.
C - Urine pH significantly affects weak acid excretion.
D - Protein binding affects distribution, not pH-dependent excretion.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 4
Q2. A client on long-term opioid therapy develops constipation. Which pharmacologi
c
approach is most appropriate?
A. Psyllium bulk-forming laxative
B. Methylnaltrexone peripherally acting mu-opioid antagonist
C. Bisacodyl stimulant laxative as needed
D. Docusate stool softener
Correct Answer: B. Methylnaltrexone peripherally acting mu-opioid antagonist
Rationale: Methylnaltrexone blocks peripheral mu-opioid receptors, relieving
opioid-induced constipation without affecting analgesia. Bulk-forming laxatives may
worsen impaction. Stimulant and stool softeners provide symptomatic relief but do not
address the opioid receptor mechanism. Methylnaltrexone is specifically indicated for
opioid-induced constipation.
Why Wrong:
A - Bulk-forming laxatives can exacerbate impaction in opioid-induced constipation.
C - Bisacodyl is not targeted therapy and may cause cramping.
D - Docusate is insufficient for opioid-induced constipation.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 14
Page 4
2026/2027 Edition | 200 Verified Questions - 190 Questions
with Answers
NR 293 Exam 3 Pharmacology for Nursing Practice 2026-190 QUESTIONS AND ANSWERS ALREADY GRADED
A+. 100% Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document is meticulously designed for nursing students enrolled
in NR 293 Pharmacology for Nursing Practice. It contains 200 verified questions that reflect the actual
exam content, providing detailed rationales for each answer to enhance understanding and retention.
The material is organized to cover all major pharmacological principles, drug classifications, and
nursing interventions, ensuring a thorough review. With a focus on clinical application and safety, this
resource is an indispensable tool for achieving a top grade in the course.
Key Features:
Pharmacokinetics and Pharmacodynamics: Absorption, Distribution, Metabolism, Excretion, and
Drug-Receptor Interactions
Drug Classification and Prototype Drugs: Major Classes Including Antibiotics, Analgesics, Cardiovascular, and
CNS Agents
Nursing Process in Pharmacology: Assessment, Diagnosis, Planning, Implementation, and Evaluation
Patient Education and Health Promotion: Medication Teaching, Adherence, and Lifestyle Modifications
Safety and Error Prevention: High-Alert Medications, Look-Alike/Sound-Alike Drugs, and Adverse Reaction
Monitoring
Legal and Ethical Considerations: Controlled Substances, Prescriptive Authority, and Patient Rights
Cultural and Lifespan Considerations: Pediatric, Geriatric, Pregnancy, and Cultural Variations in Drug
Response
Herbal and Over-the-Counter Medications: Interactions and Nursing Implications
Antimicrobial Therapy: Antibiotics, Antivirals, Antifungals, and Resistance Mechanisms
Cardiovascular Pharmacology: Antihypertensives, Antiarrhythmics, Antianginals, and Lipid-Lowering Agents
Respiratory Pharmacology: Bronchodilators, Corticosteroids, and Antihistamines
Neurological and Psychiatric Pharmacology: Anticonvulsants, Antidepressants, Antipsychotics, and
Anxiolytics
Endocrine Pharmacology: Insulin, Oral Hypoglycemics, Thyroid Hormones, and Corticosteroids
Gastrointestinal Pharmacology: Antacids, Antiemetics, Laxatives, and Antidiarrheals
Renal and Fluid/Electrolyte Pharmacology: Diuretics, Electrolyte Supplements, and Acid-Base Regulators
Oncology and Immunomodulators: Chemotherapeutic Agents, Biologic Response Modifiers, and
Immunosuppressants
Emergency and Critical Care Pharmacology: Vasopressors, Antidotes, and Reversal Agents
Pain Management and Anesthesia: Opioids, NSAIDs, Local and General Anesthetics
Updates for 2026:
- Updated to reflect the latest 2026/2027 NR 293 exam blueprint and course objectives
- Incorporated recent FDA drug approvals and safety alerts relevant to nursing practice
- Enhanced rationales with evidence-based guidelines from the American Nurses Association and specialty
organizations
- Revised to include new NCLEX-style questions that emphasize clinical judgment and prioritization
- Expanded coverage of high-alert medications and medication error prevention strategies
Page 1
,Abstract:
This exam preparation document for NR 293 Pharmacology for Nursing Practice is a meticulously curated
collection of 200 verified questions and answers, designed to mirror the actual 2026/2027 Chamberlain University
exam. Each question is accompanied by a detailed rationale that explains the correct answer and distracts the
incorrect options, facilitating a deep understanding of pharmacological principles and their clinical applications.
The content spans the entire course syllabus, from foundational concepts of pharmacokinetics and
pharmacodynamics to complex drug therapies across various body systems. Emphasis is placed on the nursing
process, patient safety, and evidence-based practice, ensuring that students are well-prepared not only for the
exam but also for real-world nursing scenarios. The document is structured to promote active recall and critical
thinking, with questions that range from basic recall to application and analysis. By engaging with this material,
students will reinforce their knowledge, identify areas for improvement, and build confidence to excel in the exam
and in their future nursing careers.
Keywords:
NR 293 Exam 3, Pharmacology for Nursing Practice, Chamberlain University, Verified Questions, Detailed
Rationales, NCLEX-style, Nursing Pharmacology, 2026-2027
Answer Format:
Each question is presented in a multiple-choice format with four options. The correct answer is indicated, followed
by a comprehensive rationale explaining why it is correct and why the other options are incorrect. Rationales
include pharmacological mechanisms, nursing considerations, and clinical pearls to reinforce learning and
application.
Compliance Checklist:
Aligned with Chamberlain University NR 293 course objectives and exam blueprint
Updated to reflect 2026/2027 academic year and current clinical guidelines
Includes 100% verified questions and answers with detailed rationales
Covers all major drug classifications and nursing implications
Designed to promote critical thinking and clinical judgment
Suitable for NCLEX-RN preparation and pharmacology mastery
Content Area Overview:
Content Area Questions Key Topics Weight
Pharmacokinetics and 1-20 Absorption, Distribution, Metabolism, 10%
Pharmacodynamics Excretion, Drug-Receptor Interactions,
Half-Life
Drug Classification and 21-40 Major Drug Classes, Prototype Drugs, 10%
Prototype Drugs Therapeutic Equivalence
Nursing Process and Patient 41-60 Assessment, Planning, Implementation, 10%
Education Evaluation, Teaching Strategies
Safety and Error Prevention 61-80 High-Alert Medications, 10%
Look-Alike/Sound-Alike, Adverse
Reactions, Medication Reconciliation
Antimicrobial Therapy 81-100 Antibiotics, Antivirals, Antifungals, 10%
Resistance, Culture and Sensitivity
Cardiovascular Pharmacology 101-120 Antihypertensives, Antiarrhythmics, 10%
Antianginals, Lipid-Lowering Agents
Respiratory and Neurological 121-140 Bronchodilators, Corticosteroids, 10%
Pharmacology Anticonvulsants, Antidepressants,
Antipsychotics
Page 2
,Endocrine and Gastrointestinal 141-160 Insulin, Oral Hypoglycemics, Thyroid 10%
Pharmacology Hormones, Antacids, Antiemetics
Renal and Fluid/Electrolyte 161-180 Diuretics, Electrolyte Supplements, 10%
Pharmacology Acid-Base Regulators
Oncology, Emergency, and Pain 181-200 Chemotherapy, Immunomodulators, 10%
Management Vasopressors, Antidotes, Opioids, NSAIDs
Page 3
, Q1. A client receiving a drug that is a weak acid has a urine pH of 8.5. How does this
affect drug excretion?
A. Increased reabsorption, reduced excretion
B. Increased excretion due to ion trapping
C. No change in excretion
D. Decreased excretion due to protein binding
Correct Answer: B. Increased excretion due to ion trapping
Rationale: Weak acids ionize in alkaline urine, becoming less lipid-soluble and unable to
cross tubular membranes, thus increasing excretion. Option A describes the effect in acidi
c
urine. Option C is incorrect because pH alters ionization. Option D is unrelated to pH
effects.
Why Wrong:
A - This is the opposite: weak acids are reabsorbed in acidic urine.
C - Urine pH significantly affects weak acid excretion.
D - Protein binding affects distribution, not pH-dependent excretion.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 4
Q2. A client on long-term opioid therapy develops constipation. Which pharmacologi
c
approach is most appropriate?
A. Psyllium bulk-forming laxative
B. Methylnaltrexone peripherally acting mu-opioid antagonist
C. Bisacodyl stimulant laxative as needed
D. Docusate stool softener
Correct Answer: B. Methylnaltrexone peripherally acting mu-opioid antagonist
Rationale: Methylnaltrexone blocks peripheral mu-opioid receptors, relieving
opioid-induced constipation without affecting analgesia. Bulk-forming laxatives may
worsen impaction. Stimulant and stool softeners provide symptomatic relief but do not
address the opioid receptor mechanism. Methylnaltrexone is specifically indicated for
opioid-induced constipation.
Why Wrong:
A - Bulk-forming laxatives can exacerbate impaction in opioid-induced constipation.
C - Bisacodyl is not targeted therapy and may cause cramping.
D - Docusate is insufficient for opioid-induced constipation.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 14
Page 4
